The EUROSCA Natural History Study

NCT02440763 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-06-29

No results posted yet for this study

Summary

The key goals of EUROSCA-NHS is to determine and compare the rate of disease progression in SCA1, SCA2, SCA3 and SCA6 including determination of the order and occurrence of non-ataxia symptoms, assessment of activities of daily living (ADL) and quality of life (QoL), and identification of predictors of disease progression and survival.

Conditions

  • Spinocerebellar Ataxia

Sponsors & Collaborators

  • Ataxia Study Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2050-07-31
Completion
2050-07-31

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02440763 on ClinicalTrials.gov